Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Mocellin

Showing results (241-250 of 257) with videos related to

Pageof 26
Sort By:
Cancers|February 24, 2024
Kaposi's Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case SeriesIrene Russo, Dario Marino, Claudia Cozzolino, et al.
European Urology|July 4, 2012
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomyGiacomo Novara, Vincenzo Ficarra, Simone Mocellin, et al.
BMC Cancer|June 6, 2022
The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086)Saveria Tropea, Paolo Del Fiore, Andrea Maurichi, et al.
Cancer Research|July 5, 2002
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsivenessEna Wang, Lance D Miller, Galen A Ohnmacht, et al.
Frontiers in Medicine|August 24, 2023
Indicators of clinical performance in monitoring soft tissue sarcoma management: a population-based perspectiveMassimo Rugge, Alessandra Buja, Saveria Tropea, et al.
Annals of Surgical Oncology|January 10, 2009
Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI)Alessandro Testori, Gian Luca De Salvo, Maria Cristina Montesco, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2020
Corrigendum to "Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicenter study of the Italian Melanoma Intergroup (IMI)" [Eur J Canc 137 (2020). Pages 30-39]Mario Mandalà, Francesca Galli, Roberto Patuzzo, et al.
International Journal of Molecular Sciences|December 11, 2022
TRK Protein Expression in Merkel Cell Carcinoma Is Not Caused by <i>NTRK</i> FusionsRocco Cappellesso, Lorenzo Nicolè, Paolo Del Fiore, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2020
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)Mario Mandalà, Francesca Galli, Roberto Patuzzo, et al.
BMC Cancer|January 6, 2021
The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity ratesAntonella Vecchiato, Simone Mocellin, Paolo Del Fiore, et al.
Pageof 26

Showing results (241-250 of 257) with videos related to

Sort By:
Pageof 26
Cancers|February 24, 2024
Kaposi's Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case SeriesIrene Russo, Dario Marino, Claudia Cozzolino, et al.
European Urology|July 4, 2012
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomyGiacomo Novara, Vincenzo Ficarra, Simone Mocellin, et al.
BMC Cancer|June 6, 2022
The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086)Saveria Tropea, Paolo Del Fiore, Andrea Maurichi, et al.
Cancer Research|July 5, 2002
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsivenessEna Wang, Lance D Miller, Galen A Ohnmacht, et al.
Frontiers in Medicine|August 24, 2023
Indicators of clinical performance in monitoring soft tissue sarcoma management: a population-based perspectiveMassimo Rugge, Alessandra Buja, Saveria Tropea, et al.
Annals of Surgical Oncology|January 10, 2009
Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI)Alessandro Testori, Gian Luca De Salvo, Maria Cristina Montesco, et al.
European Journal of Cancer (Oxford, England : 1990)|September 27, 2020
Corrigendum to "Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicenter study of the Italian Melanoma Intergroup (IMI)" [Eur J Canc 137 (2020). Pages 30-39]Mario Mandalà, Francesca Galli, Roberto Patuzzo, et al.
International Journal of Molecular Sciences|December 11, 2022
TRK Protein Expression in Merkel Cell Carcinoma Is Not Caused by <i>NTRK</i> FusionsRocco Cappellesso, Lorenzo Nicolè, Paolo Del Fiore, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2020
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)Mario Mandalà, Francesca Galli, Roberto Patuzzo, et al.
BMC Cancer|January 6, 2021
The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity ratesAntonella Vecchiato, Simone Mocellin, Paolo Del Fiore, et al.
Pageof 26